
Sign up to save your podcasts
Or


As medical devices keep advancing, the consumables used in testing and therapeutics are moving forward as well, far beyond grandpa’s diabetes test strips. New semiconductors, circuitry, and sensors, along with automated production, bring a whole new spectrum of functionality within reach for consumables.
The burgeoning at-home market is driving demand and the growth of body-worn therapeutics and delivery devices. But with new functionality comes new risks, and among the biggest risks is human error. To paraphrase Murphy’s Law, “Anything that can be misused, will be misused.”
Complex consumables are our topic du jour. Mechanical Engineers Will DeMore and Andy Rogers engage in a far-ranging discussion of the ins and outs of consumables development, how to avoid pitfalls, and how to engineer your way to success.
Need to know:
The nitty-gritty:
Consumable products, whether they’re for in-home or clinical use, fall into two categories: single-use, such as blood-test strips, or multiple-use, such as CPAP masks. Each has its own special considerations. But regardless of whether your device is single-or multiple-use device, a therapeutic device, testing device, or drug delivery system, interfaces are the areas where your product will succeed or fail.
Interfaces are where you’ll encounter the most constraints and most complexity in design. For example, a body-worn consumable in a home setting has an interface between the device and user, the device and electronics, the device and its physical space, as well as the device and the digital world, i.e., smartphone app.
Keep the user experience topmost in your mind and your design. It pays to put some time into “poka-yoking” your product. (Poka-yoke is the Japanese term for "mistake-proofing.") It can be as simple as a “This side up” sticker, color-coding, or creating a plug-in that only works one way, a la Apple.
Consider number and types of sensors needed. If you’re dealing with gases or liquids, you’ll need a reliable seal to prevent backflow and cross-contamination – preferably with haptic feedback – so your user knows when the connection is secure. For multi-use consumables, factors like ingress protection, cleanability, and durability, come into play.
Depending on the type of device, you can upgrade interfaces at development or add them later. The important thing is to take a risk-based approach in your design. Think ahead and design to assembly to reduce time and scrap. Think about the cost vs. benefit of upgrades. And, of course, safety first.
The bottom line on complex consumables, whether starting from scratch or adding new functionality to an existing device, is to look for places to add value. Optimize the user experience. Add new data or new connectivity. Prompt the user when it’s time to re-supply. The more you succeed in simplifying a complex consumable for the user, the more successful your product will be.
HELPFUL LINKS:
https://sixsigmadsi.com/poka-yoke/
When you’re trying to add new functionality to existing technology, the data you need won’t be presented on a silver platter. Sometimes, you don’t even know what the right data is until you find it. This was the case with RevMedica, a start-up that’s developing a new hybrid robotic laparoscopic stapler technology.
Following Andy Rogers’ talk with RevMedica, he and electrical engineer Rachael Scott discussed the search for data when designing new functionality into existing platforms.
Need to know:
The nitty-gritty:
Clinicians want it all when it comes to medical technology, but they don’t want to pay for it all, especially in the highly competitive hospital market. So when you’re adding new functionality to existing systems – or even developing a disruptive new technology – you must pick and choose features that will make your product stand out without breaking the bank.
There are a few ways to find and evaluate the data you need to successfully bring your product to market.
Above all, remember, there’s power in the data, and collecting the data as you develop new products helps inform another generation of technology.
Helpful Links:
https://www.revmedica.comHome | revmedica
Following the data leads to a breakthrough idea in laparoscopic surgery.
Sometimes a technology starts off in one direction, but the data leads developers somewhere else entirely. This is the case for RevMedica, an early-phase medical device company, and manufacturer.
The first product in development at RevMedica is a cybernetic laparoscopic surgical stapler. The development of this device may transform the $4.5B surgical market by matching a reusable power module with a disposable sterile body. But it didn’t exactly start that way.
Recently, Tom Wenchell CEO, and Robert Satti CTO, of RevMedica talked with Andy Rogers of KeyTech about how a venture to create a full robotic surgery platform turned into an even better idea, by following the data path.
Need to know:
· Sometimes data can lead you in a new direction. Follow it.
· Start-ups must learn to do more, with fewer prototypes
· Data mapping puts performance on view for users and investors
· There’s a balancing act between development and marketing
The nitty-gritty
Surgical stapling is a workhorse technology. Staplers are used every day to dissect and/or ligate soft tissue in abdominal and thoracic cavity surgery.
Surgical staplers are nothing new. But the mechanical devices – and even the powered devices – have well-known drawbacks. They don’t fit every hand, can be tiring to use, create waste, and rely on the surgeon to feel his or her way around inside the soft tissue.
RevMedica’s technology is designed to effectively bridge the gap between the instrument and the surgeon’s hand. It’s a hybrid device, not a full robotic system. It’s designed to give surgeons a tool to make better decisions in the OR and create better patient outcomes.
Different types of data have shaped each step of the development:
Market data drove initial development. As RevMedica Interviewed surgeons, their original concept for a full robotic stapling device fell by the wayside, and the hybrid model began to emerge.
Competitive data helped refine and develop the hybrid concept. They looked at entire systems to find inefficiencies in mechanical and powered devices. It became apparent that a hybrid architecture enabled better articulation, smart firing, and a significant competitive advantage: the durable component can remain sterile for multiple procedures. And durable components reduce the waste of “one-and-done” mechanical staplers. This way, RevMedica can provide more value, at a lower cost, without all the bells and whistles or full-on robotics.
Ergonomic data from workflows and job functions surrounding the device as well as the way the device works with tissue provided valuable insight. Different aspects of workflow in OR were scored and ranked, then aggregated in spreadsheets and graphs. By making the data visual, RevMedica developers created a useful tool to define user needs, evaluate performance, and demonstrate the viability and value of the technology for investors.
Give the episode a listen!
Learn more about RevMedica: https://www.revmedica.com/
Get feedback early to fast-track your robotics design.
Start-ups that inherit robotic prototypes from universities or research labs often get caught up trying to get a product out the door. Instead, they should focus on designing a product that will be competitive in the market. Following a chat with Dave Saunders, CTO at Galen Robotic, Andy Rogers sat down with Key Tech Sr. Mechanical Engineer, Danica Mackesey, to discuss the challenges and pitfalls of designing medical robotics.
Need to know:
The nitty-gritty:
The first step in designing for quality is to determine the requirements of the robotics system, including the when, where, and how the system will be used and what features are needed. Once the features have been determined, it’s time to consider how well they work for the end-user. This is the audience participation segment of product development, where user input can save you lots of time and trouble.
In robotic surgery, surgeons need to feel comfortable and confident with the device. For example, consider the ergonomics of handles and the effects of repetitive motions. Monitors should be easy to view. Of course, a high-voltage robotic system must be safe (Your mantra is, “IEC 60601, IEC 60601, IEC 60601…”), and it also must fit into the environment of the operating room without danger of tipping over or dangling cables, and out of the way of surgical drapes. The earlier you tackle these issues, the better.
Temper your forward-thinking design with some down-to-earth risk management. For instance, what happens if the robot stops working in the middle of a procedure? That kind of thinking leads you to designing-in overrides and safety systems.
Finally, the answers to many of your design questions (and challenges) are often as near as the phone or email. Ask your end-users. Ask your component manufacturers – they have almost as much riding on your success as you do, and they can provide valuable advice.
Give it a listen!
The data you need to design a multi-use surgical robot
Surgical robots can do all sorts of things better than humans. But human doctors have a breadth of experiential knowledge and instinct robots cannot replicate anytime soon. Understanding that difference is the key to designing a successful robotic platform. Galen Robotics is expanding the benefits of minimally invasive surgeries by enabling precise surgical maneuvers through human-machine cooperation.
Andy Rogers of Key Tech and Dave Saunders, CTO at Galen Robotics, discuss the challenges of designing surgical robots and the importance of collecting key data early in the design process.
Need to know:
The nitty-gritty:
Robots are transforming surgery, making it faster, safer, and less invasive. But the majority of surgical robots on the market today are one-trick ponies.
Galen has a unique technology for delicate ear, nose, and throat (ENT) procedures that could have many applications. Leveraging different types of data gave Galen Robotics an advantage in the market.
A priori knowledge. Galen recognized an unmet need in the marketplace and licensed a concept that was initially developed at Johns Hopkins, so they didn’t have to start from scratch. The robot is not the surgical tool; it is a stabilizing platform that holds and manipulates an ordinary surgical tool similar to power steering in a car. Galen Robotics engineers capitalized on the fact that surgeons know how to use the tools of their trade; they just need a helping hand to use the tools more effectively.
This collaborative approach enables surgeons to focus on what they do best –analyze the situation and decide on a course of action– because the surgical robot stabilizes the instruments and facilitates the procedure.
Observational data. Engineers went into the OR to see which aspects of specific procedures surgeons found the most challenging to see first hand the scale of motion delicate ENT procedures require. This information proved valuable in driving components choices and materials.
Qualitative data. Surgeons have performed head and neck surgeries for decades, so they know what a successful surgery “feels” like. They already have the touch. In this case, engineers were able to use kinematics to turn this trove of anecdotal information into Quantitative data.
Quantitative data. Engineers then quantified surgical movements to adjust the “feel” and “tune out” normal hand tremor. This made surgical motions performed by the surgeon feel more natural. They also added in range-of-motion safeguards to help prevent accidental damage to surrounding tissues.
Prototyping is essential throughout the whole development process . The more, the better– because no matter how crude– each prototype yields valuable user feedback. For example, one Galen Robotics prototype was modeled on the children’s game “Operation”. Doctors at a conference tried to beat the robot, picking a small part out of a slot. Only one succeeded. And Galen Robotics’ concept was validated.
But ultimately, one of the most innovative ideas Galen Robotics is developing may not be their engineering, but a unique go-to-market plan. A plan that helps hospitals avoid the capital-intensive cost of adding another surgical robotic platform, by licensing a Galen Robotics device once it’s approved.
Give it a listen.
HELPFUL LINKS:
https://www.galenrobotics.com/
Clinical and in-home trials are different, but the essentials are the same –solid data, foresight, and flexibility.
Clinical trials are understandably rigorous, but in-home trials add a few wild cards into the mix. Andy and Jake spoke with Steve Schaefer, CEO of CoolTech, about this exact topic in the previous episode.
Here, Andy and Jake dig into in-home trial design and execution from a product development perspective.
Need to know:
The nitty-gritty
By now, it’s pretty clear that the future growth of med-tech points towards in-home testing and therapy. But you have to jump through more hoops from prototype to commercialization for in-home devices. As the Boy Scout motto says, “Be prepared.”
Plan for change. Start with a change control process in place so that you don’t make changes that could negatively affect performance down the road. Evaluate your device against all applicable standards at appropriate milestones.
Know your user. Clinical users are different from your home user, and each will need different training to use and evaluate the device correctly.
Keep it simple. A clinical device may not need all the bells and whistles of a commercial device, so keep it as simple as you can. With in-home trials, you don’t have trained clinicians and engineers on hand to monitor the process, so once again, make it simple for users to get it right the first time. For example, with the MiHelper in-home trials, CoolTech used disposable tubes and masks to simplify use and facilitate the trials; commercial products will be multiple use.
To get from trial to commercial success, you need to:
There are more details and more insight in the podcast. Check it out.
CoolTech Part 2: Get through trials faster, with fewer tribulations.
Here, Andy Rogers and Jake Cowperthwaite continue their talk with Steve Schaefer, CEO at CoolTech, about the quest for data with MiHelper: a new in-home therapy device.
MiHelper is a drug-free way to treat migraines, cooling the patient with air. The design for the device was piggy-backed (pun intended, as they used a porcine animal model for the original device) onto an existing cooling platform –CoolStat– used for a totally different type of therapy. Even though the platform itself was proven, MiHelper still had to go through the twists and turns of trials because it was a de novo device in this application.
Need to know:
The nitty-gritty:
Oxygen therapy has been used to treat migraines in the past, but devices were too bulky and complex for at-home use, until a prototype study at Johns Hopkins indicated that room temperature air could do the job. When CoolTech worked with their engineering partner to adapt their existing CoolStat evaporative cooling platform, the objective data panned out, and patients reported relief from migraines using the device. So MiHelper was born. That was the easy part, relatively speaking.
The thorny path is the road to clinical trials, in-home trials, regulatory approval and ultimately, commercialization. For clinical trials in this case, a subject had to develop a migraine, travel to the hospital, receive the therapy, and then report about relief – a lag time of several hours.
At-home trials require an additional level of device confidence, which is being achieved through design verification, biocompatibility testing, and electrical safety & EMC testing. There are more wild cards, starting with shipping the device to test subjects. (CoolTech found a contract manufacturer who could drop-ship and re-process them). Recruiting test subjects was done through social media, and because the data is digital, the study center doesn’t have to be local, allowing for larger sample sizes. Data tracking and security is another big issue that CoolTech solved with a one-way app.
To speed the whole process along, CoolTech developed the trial device and in-home platforms concurrently. To support at-home trials, CoolTech is using a “small-but-mighty” team of in-house people and contractors, which allows for flexibility and quick response. This way, they can channel resources into generating high-quality evidence and driving value.
The MiHelper trials have yielded a couple of valuable tips for any start-ups going into home trials.
1. Try to partner up with emerging companies using convergent technologies.
2. Partners could range from privately funded research to oversight by a clinic, or anything in between.
2. When evaluating data, it’s the quality of the evidence, not the name on the paper, that counts.
The market for in-home therapy is growing by leaps and bounds. And the profit potential is huge. But get your ducks in a row before you jump into the pond. That way, the path from drawing board to commercialization will be smoother and more straightforward.
There’s more. The whole story is right here, and well worth a listen.
HELPFUL LINKS:
https://www.cooltechcorp.com/
https://www.nih.gov/
You don’t know where test data will lead, but you can follow it if you plan ahead
A few weeks ago Andy and Jake Cowperthwaite spoke with Steve Schaefer, CEO of CoolTech, about designing your device as a platform. Steve’s company was able to use their temperature management platform to develop two devices, for two distinct applications.
They were able to achieve this by designing enough flexibility into the initial design, which is what Andy and Jake discuss in depth this time around.
Need to know:
The nitty-gritty:
When thinking about flexibility, there are four core elements to keep in mind.
Flexibility in Software Design
Plan for software upgrades and how you will deliver them. Plan to log as much data as possible, because you never know what data you will need.
Flexibility in Electrical Design
Ensure your power supply can support new features. Include hooks on circuit boards for future sensors and actuators.
Flexibility in Mechanical Design
Focus on modularity, so you can change parts of the hardware without impacting the entire device.
Flexibility in Serviceability
Focus on easy access to internal components, and make disassembly and reassembly as easy as possible.
While you can’t plan for everything, doing preformative testing early, and letting your prospective end users tell you what the ideal product architecture and use case should be. This way, once you get into a trial, the development changes are very technical in nature, rather than being due to the device not being easy to use.
For a great example of how to do this, take a listen to our interview with Steve Schaefer.
HELPFUL LINKS:
https://www.cooltechcorp.com/
https://www.nih.gov/
How to get from “data” to “device”: one cool story.
What data you need, where you get it – and most importantly – what you do with it, all determine whether a medical device will be successful. Of course, every technology has its own set of caveats, but it always helps to hear from people who have been there.
In this episode, VP of Business Development Andy Rogers, and Senior Electrical Engineer/Partner Jake Cowperthwaite, both of Key Tech, talk with Steve Schaefer, CEO at CoolTech, about the quest for data with CoolStat: a new way to manage patient temperature in fever that can develop following a stroke, traumatic brain injury, seizure, or metabolic encephalopathy.
There are other technologies that manage patient temperature, but CoolTech partnered with a engineering team to build a way build a better mousetrap. CoolStat generates filtered air that’s delivered to the patient via a nasal mask air tubing set. It cools through evaporative cooling, using room temperature air. CoolStat is smaller and lighter than existing devices; it reduces side effects like shivering which can lead to complications – and shortens treatment time.
Need to know:
● Understand the commercial product requirements before you start
● Your regulatory path depends on your specific device
● Go where the data leads
The nitty-gritty:
The initial data that drove CoolStat’s development was collected from tests on pigs, who have similar physiology to humans. In this case, because they were seeking objective data – rate of cooling, rate of air flow and efficiency of cooling – CoolTech was able to save time by using existing temperature probes and storage software.
The first results were okay, but less than optimal. For many companies, this can be a go/no-go point, where you decide to fish or cut bait. CoolTech opted to pause the study, make changes, and go back to the FDA with an improved device.
Finding human subjects for testing was another challenge. Patients are typically unconscious in the ICU, so getting family consent is laborious, especially during the COVID pandemic. Patient data is recorded on CRF’s and validated within 24 hrs. so engineers can quickly make changes based on this real-world info.
CoolTech found that partnering with outside resources, such as the National Institutes for Health (NIH) university hospitals, and end-user associations can help to expedite development. Clinical studies will be completed soon. Now the critical numbers for CoolStat are the savings that hospitals can reap using this exciting new technology.
Listen in for more data. And more details.
HELPFUL LINKS:
https://www.cooltechcorp.com/
Managing Blood When Evaluating Consumable / Durable Medical Devices
“Blood is thicker than water” the old saying goes. There’s truth in that adage, especially when it comes to designing and running de-risking experiments of blood processing systems.
Whole blood is a two-phase fluid, comprised of both cells and plasma. Under pressure, it’s fickle and unpredictable. And those unique fluidics present distinctive challenges in designing medical devices.
Blood management is the central concept in cardiac care, the largest segment of the medical device market. As the home care market continues to grow and devices become smaller, blood management becomes a more and more critical design issue.
This month, Mechanical Engineer Katie Goetz and Andy Rogers of Key Tech talk blood: how it poses problems in medical device design, and how to get blood to do what you want it to do.
Need to know:
Why blood fluidics are different
How to engineer your device for optimum flow control
How storage methods, freshness of samples, and interactions can affect test results
How to deal with bubbles
The nitty-gritty:
A blood analog may work fine in the early stages of testing, but nothing replaces testing with the real thing. Whole blood is thick and complex, and the viscosity varies due to many factors. That makes for some challenges when you want to make blood flow the way you want it in a complex consumable. Blood differs from person to person too, so medical devices must be capable of dealing with a wide range of conditions. Blood also interacts with metals, plastics, and air differently, which can also skew test results, so proper cleaning of prototypes is critical. And then there’s foaming, which adds risk and time to your test planning.
Even the logistics of blood are complex. Anyone who’s doing testing needs to be trained how to work with blood and clean it up. Ordering blood takes a few days, and sample blood may need to contain additives like EDTA or other anticoagulants, so when you are designing and running experiments, you have to take this into account.
As we said, blood is complicated. But if you take it step-by-step, and follow the protocols, you can make blood behave the way you want it to. And you’ll make your device all that more robust.
Helpful links
https://www.iso.org/standard/38421.html
From the publisher's feed